benzylamine has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjørkøy, G; Bugge, S; Hoff, BH; Kaspersen, SJ; Larsen, S; Nonstad, U; Sundby, E | 1 |
1 other study(ies) available for benzylamine and Neoplasms
| Article | Year |
|---|---|
Structure-activity study leading to identification of a highly active thienopyrimidine based EGFR inhibitor.
Topics: Antineoplastic Agents; Benzylamines; Cell Line, Tumor; ErbB Receptors; Humans; Models, Molecular; Neoplasms; Protein Kinase Inhibitors; Pyrimidines | 2014 |